Sudarshan Chemical lines up meet with Abakkus after Heubach deal
Abakkus Diversified Alpha Fund, a long-only institutional investor, will hold one-on-one talks with Sudarshan on June 17. The meeting comes two months after the company set **€35M** EBITDA targets for Heubach.
— 6 earlier stories on Sudarshan Chemical Industries Ltd. →What's new
- Meeting with Abakkus Diversified Alpha Fund scheduled for June 17.
- Abakkus is a prominent institutional investor known for long-term holdings.
- The company says no unpublished price-sensitive info will be discussed.
Why this matters
Abakkus' engagement is a vote of confidence in Sudarshan's turnaround story—especially the Heubach acquisition. For a mid-cap with a market cap of ₹7,150 cr, such investor attention can improve visibility and liquidity.
What we're watching
- Whether the meeting leads to a larger stake by Abakkus.
- Heubach's EBITDA progress toward the €35M target.
- Promoter family's exit timeline after the step-back announcement.
The full read
Sudarshan Chemical's meeting with Abakkus is the latest sign that institutional interest is building after the Heubach acquisition. The company set a €35M EBITDA target for Heubach, and the promoter family is stepping back. Both moves could lead to a change in ownership structure. It's just a meeting. No new information will be shared. Still, for a mid-cap with a ₹7,150 cr market cap, having Abakkus on the call is a positive signal. The open question is whether Abakkus translates this meeting into a meaningful stake. Given the promoter's planned exit and Heubach's turnaround, the meeting could be a prelude to deeper institutional involvement.
Questions answered
- Why is this meeting significant?
- Abakkus is a well-known institutional investor with a long-term focus. Its engagement signals potential confidence in Sudarshan's strategy, especially after the Heubach acquisition and the promoter family's plan to exit management.
- What is Abakkus Diversified Alpha Fund?
- Abakkus is a prominent Indian institutional investor managed by Abakkus Asset Manager LLP, known for concentrated, long-term bets in mid-cap and small-cap equities.
- What is the status of the Heubach acquisition?
- Sudarshan completed the Heubach acquisition earlier this year and has guided for €35M EBITDA from the business in the current financial year. The March quarter already posted ₹11 cr positive EBITDA from Heubach.
- Did the company provide any new financial information in this filing?
- No. The filing only intimates a scheduled investor meeting. The company explicitly stated it will not discuss any unpublished price-sensitive information.
- What are the key targets for Heubach?
- Sudarshan has set a €35M EBITDA target for Heubach in FY27, after achieving ₹11 cr positive EBITDA in the March quarter. The company also reported ₹2,790 cr sales and ₹77 cr net profit for that quarter.
Sudarshan Chemical Industries Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on SUDARSCHEM →- 15 Jun 2026 · 9:36 PM IST Sudarshan Chemical lines up meet with Abakkus after Heubach deal
- 11d ago Sudarshan's promoter family plans to step back from management
- 19d ago Sudarshan Chemical's Rathi family plans to exit promoter status
- 21d ago Sudarshan Chemical sets targets for its Heubach acquisition
- 21d ago Sudarshan Chemical confirms FY26 profit, recommends ₹5 dividend